Literature DB >> 15500705

Signal transduction abnormalities in melancholic depression.

Demet Akin1, D Hal Manier, Elaine Sanders-Bush, Richard C Shelton.   

Abstract

Intracellular signal transduction cascades, particularly those linked to protein kinases A (PKA) and C (PKC), have been implicated in mood disorders. This study examined the activity of PKA and PKC, as well as levels of PKA regulatory (R) and catalytic (C) subunit proteins, in fibroblasts cultured from skin biopsies from patients with major depression, melancholic subtype, in contrast to non-melancholic depressives and controls (n = 12 each group). PKA activity was determined as a function of the transfer of 32P to a target polypeptide, Kemptide. R and C subunit expression was assayed in the melancholic depressed and normal control groups by Western blots. In a separate experiment, the degree of phosphorylation of the endogenous substrate cAMP response element-binding protein (CREB) was estimated in samples from melancholic and non-melancholic patients and normal controls (n = 8 each) after incubation with isoproterenol or phorbol ester, which activate PKA and PKC respectively. Melancholics had significantly reduced phosphorylation of Kemptide in contrast to non-melancholics and controls. This was associated with lower levels of PKA RII alpha, C alpha, and C beta subunit isoform proteins, but not RI alpha, RI beta, or RII beta. Furthermore, activation of both PKA and PKC was associated with reduced CREB-P in melancholics relative to normal controls. Finally, PKA activity was found to correlate positively with Hamilton depression scores after 16 weeks of treatment with serotonin reuptake inhibitor antidepressants. These data further implicate signal transduction abnormalities in melancholic major depression, particularly PKA and PKC. This suggests an abnormality of factors controlling the expression or degradation of these enzymes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500705     DOI: 10.1017/S146114570400478X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  24 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains.

Authors:  Ping Chen; Yan Fan; Ying Li; Zhongwen Sun; Garth Bissette; Meng-Yang Zhu
Journal:  Neurochem Int       Date:  2011-11-15       Impact factor: 3.921

3.  High activity of acid sphingomyelinase in major depression.

Authors:  J Kornhuber; A Medlin; S Bleich; V Jendrossek; A W Henkel; J Wiltfang; E Gulbins
Journal:  J Neural Transm (Vienna)       Date:  2005-11       Impact factor: 3.575

Review 4.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

5.  Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2011-07-21       Impact factor: 7.217

6.  Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.

Authors:  Harold W Koenigsberg; Peixiong Yuan; George A Diaz; Stephanie Guerreri; Christine Dorantes; Sarahjo Mayson; Constantin Zamfirescu; Antonia S New; Marianne Goodman; Husseini K Manji; Larry J Siever
Journal:  Psychiatry Res       Date:  2012-05-26       Impact factor: 3.222

7.  Activity of protein kinase C is important for 3alpha,5alpha-THP's actions at dopamine type 1-like and/or GABAA receptors in the ventral tegmental area for lordosis of rats.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Brain Res Bull       Date:  2008-07-31       Impact factor: 4.077

8.  Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.

Authors:  Richard C Shelton; D Hal Manier; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-02       Impact factor: 5.176

9.  Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.

Authors:  Krassimira A Garbett; Andrea Vereczkei; Sára Kálmán; Jacquelyn A Brown; Warren D Taylor; Gábor Faludi; Željka Korade; Richard C Shelton; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2014-06-02       Impact factor: 13.382

10.  An altered peripheral IL6 response in major depressive disorder.

Authors:  Kelli M Money; Zita Olah; Zeljka Korade; Krassimira A Garbett; Richard C Shelton; Karoly Mirnics
Journal:  Neurobiol Dis       Date:  2016-01-22       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.